Markera | Cases diagnosed within 1 year after blood collection | Cases diagnosed more than 1 year after blood collection | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
NPCs | Controls | OR1 (95% CI) | OR2 (95% CI) | OR3 (95% CI) | NPCs | Controls | OR1 (95% CI) | OR2 (95% CI) | OR3 (95% CI) | |
MIP-1α | ||||||||||
Category 1 | 8 | 14 | Reference | Reference | Reference | 12 | 17 | Reference | Reference | Reference |
Category 2 | 4 | 9 | 0.70 (0.18–2.81) | 2.68 (0.20–35.6) | 1.03 (0.14–7.60) | 10 | 20 | 0.81 (0.28–2.36) | 0.68 (0.18–2.61) | 0.59 (0.15–2.37) |
Category 3 | 9 | 15 | 0.94 (0.21–4.18) | 10.14 (0.58–177) | 1.76 (0.33–9.51) | 12 | 15 | 1.13 (0.36–3.54) | 0.62 (0.12–3.29) | 1.21 (0.31–4.70) |
Category 4 | 2 | 10 | 0.32 (0.05–1.86) | 0.80 (0.06–10.2) | 0.10 (0.01–2.39) | 2 | 20 | 0.16 (0.03–0.81) | 0.07 (0.01–0.82) | 0.09 (0.01–0.82) |
P trend | 0.462 | 0.450 | 0.312 | 0.020 | 0.032 | 0.036 | ||||
MIP-1β | ||||||||||
Category 1 | 6 | 13 | Reference | Reference | Reference | 15 | 17 | Reference | Reference | Reference |
Category 2 | 7 | 13 | 1.16 (0.31–4.34) | 1.28 (0.20–8.42) | 1.79 (0.22–14.7) | 10 | 17 | 0.72 (0.26–2.00) | 0.41 (0.10–1.74) | 0.38 (0.09–1.59) |
Category 3 | 7 | 14 | 1.08 (0.31–3.83) | 1.23 (0.22–6.78) | 1.62 (0.20–13.3) | 7 | 14 | 0.64 (0.21–1.94) | 0.32 (0.05–1.95) | 0.30 (0.05–1.84) |
Category 4 | 4 | 8 | 1.09 (0.26–4.55) | 0.83 (0.12–5.72) | 0.96 (0.05–17.3) | 4 | 23 | 0.21 (0.06–0.74) | 0.08 (0.01–0.59) | 0.12 (0.01–0.94) |
P trend | 0.953 | 0.860 | 0.919 | 0.013 | 0.016 | 0.047 |